{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:32:39Z","timestamp":1791178359101,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"RCMI","award":["G12RR03020"],"award-info":[{"award-number":["G12RR03020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.jconrel.2011.11.016","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T00:58:42Z","timestamp":1321923522000},"page":"336-345","source":"Crossref","is-referenced-by-count":79,"title":["Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen"],"prefix":"10.1016","volume":"158","author":[{"given":"Punit","family":"P. Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinaki","family":"R. Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandip","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2011.11.016_bb0215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0928-0987(01)00167-1","article-title":"Novel mechanisms and devices to enable successful transdermal drug delivery","volume":"14","author":"Barry","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0939-6411(01)00166-7","article-title":"Passive skin penetration enhancement and its quantification in vitro","volume":"52","author":"Moser","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0225","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2006.07.001","article-title":"Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery","volume":"115","author":"Karande","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2010.05.034","article-title":"In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin","volume":"146","author":"Milewski","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0235","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2006.12.017","article-title":"Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis","volume":"118","author":"Wu","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0240","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jconrel.2011.01.006","article-title":"Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends","volume":"152","author":"Polat","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0245","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2009.10.036","article-title":"Transcutaneous electroporation mediated delivery of doxepin\u2013HPCD complex: a sustained release approach for treatment of postherpetic neuralgia","volume":"142","author":"Sammeta","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0250","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jconrel.2009.10.016","article-title":"Nanotechnology and the transdermal route: a state of the art review and critical appraisal","volume":"141","author":"Cevc","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0255","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s11095-009-9919-x","article-title":"Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy","volume":"26","author":"Rancan","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0260","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2006.10.019","article-title":"Nanoparticles\u2014an efficient carrier for drug delivery into the hair follicles","volume":"66","author":"Lademann","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0265","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0939-6411(01)00188-6","article-title":"Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection","volume":"52","author":"Alvarez-Roman","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0270","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0168-3659(01)00407-2","article-title":"Chitosan-based nanoparticles for topical genetic immunization","volume":"75","author":"Cui","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0275","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1023\/B:PHAM.0000045235.86197.ef","article-title":"Enhancement of topical delivery from biodegradable nanoparticles","volume":"21","author":"Alvarez-Roman","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0280","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1021\/mp9001188","article-title":"Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin","volume":"6","author":"Wu","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0285","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0290","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/jps.21456","article-title":"Influence of chitosan crosslinking on bitterness of mefloquine hydrochloride microparticles using central composite design","volume":"98","author":"Shah","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0295","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2010.08.020","article-title":"Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution","volume":"400","author":"Vllasaliu","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0300","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejpb.2008.08.019","article-title":"Nanoparticles for skin penetration enhancement\u2014a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles","volume":"71","author":"Kuchler","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0305","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0168-3659(87)90066-6","article-title":"Mode of action of penetration enhancers in human skin","volume":"6","author":"Barry","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0310","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0168-3659(98)00144-8","article-title":"In vivo human skin permeability enhancement by oleic acid: a laser Doppler velocimetry study","volume":"58","author":"Tanojo","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0315","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0040-6031(97)00063-4","article-title":"In vitro human skin barrier perturbation by oleic acid: thermal analysis and freeze fracture electron microscopy studies","volume":"293","author":"Tanojo","year":"1997","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0320","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.phrs.2009.04.005","article-title":"The effect of opioid antagonists on synergism between dexketoprofen and tramadol","volume":"60","author":"Zegpi","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0325","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1023\/B:PHAM.0000012157.80716.73","article-title":"Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II","volume":"21","author":"Babu","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0330","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-3659(99)00199-6","article-title":"Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug","volume":"63","author":"Valenta","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0335","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s11095-010-0103-0","article-title":"The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery","volume":"27","author":"Yuan","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0340","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1016\/j.biomaterials.2010.03.010","article-title":"Translocation of cell penetrating peptide engrafted nanoparticles across skin layers","volume":"31","author":"Patlolla","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0345","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1007\/s11095-009-9888-0","article-title":"Nanoparticle coated submicron emulsions: sustained in vitro release and improved dermal delivery of All-trans-retinol","volume":"26","author":"Ghouchi Eskandar","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0350","doi-asserted-by":"crossref","first-page":"E565","DOI":"10.1208\/pt060471","article-title":"In vitro and in vivo evaluation of topical formulations of spantide II","volume":"6","author":"Kikwai","year":"2005","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0355","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lungcan.2010.06.002","article-title":"Anticancer activity of noscapine, an opioid alkaloid in combination with cisplatin in human non-small cell lung cancer","volume":"71","author":"Chougule","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0360","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.jid.5700226","article-title":"40nm, but not 750 or 1,500nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin","volume":"126","author":"Vogt","year":"2006","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0365","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2004.06.015","article-title":"Skin penetration and distribution of polymeric nanoparticles","volume":"99","author":"Alvarez-Roman","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0370","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2008.11.002","article-title":"Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity","volume":"134","author":"Taveira","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0375","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijpharm.2009.07.038","article-title":"Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers","volume":"382","author":"He","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0380","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2007.12.050","article-title":"Transdermal permeation enhancement of N-trimethyl chitosan for testosterone","volume":"356","author":"He","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0385","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.biomaterials.2007.10.034","article-title":"The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery","volume":"29","author":"Lee","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0390","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1016\/j.biomaterials.2009.08.042","article-title":"Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice","volume":"30","author":"Jain","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0395","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ejpb.2008.06.015","article-title":"PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy","volume":"70","author":"Hu","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0400","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1016\/j.biomaterials.2005.03.036","article-title":"Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers","volume":"26","author":"Mao","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0405","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jps.20813","article-title":"Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice","volume":"96","author":"Kommareddy","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0410","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.nano.2006.11.005","article-title":"Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery","volume":"3","author":"Kommareddy","year":"2007","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0415","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1208\/s12249-010-9487-8","article-title":"Optimization of PEGylation conditions for bsa nanoparticles using response surface methodology","volume":"11","author":"Kouchakzadeh","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0420","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.nano.2007.03.006","article-title":"Chitosan-coated PLGA nanoparticles for DNA\/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides","volume":"3","author":"Nafee","year":"2007","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(02)00004-4","article-title":"Oleic acid, a skin penetration enhancer, affects Langerhans cells and corneocytes","volume":"80","author":"Touitou","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0430","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1023\/A:1015822312426","article-title":"Oleic acid: its effects on stratum corneum in relation to (trans)dermal drug delivery","volume":"7","author":"Francoeur","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0435","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0168-3659(95)00088-7","article-title":"Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans","volume":"37","author":"Naik","year":"1995","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0440","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0168-3659(98)00187-4","article-title":"Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations","volume":"59","author":"Marjukka Suhonen","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0445","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2008.04.002","article-title":"Functional characterisation of novel analgesic product based on self-regulating drug carriers","volume":"360","author":"Cevc","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0450","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijpharm.2008.01.045","article-title":"Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation","volume":"357","author":"Puglia","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0455","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0168-3659(97)00035-7","article-title":"Prevention of contact hypersensitivity to topically applied drugs by ethacrynic acid: potential application to transdermal drug delivery","volume":"48","author":"Kallish","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.11.016_bb0460","doi-asserted-by":"crossref","first-page":"10007","DOI":"10.1021\/jf102224b","article-title":"Protective effects of black rice bran against chemically-induced inflammation of mouse skin","volume":"58","author":"Choi","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0465","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/1523-1747.ep12330326","article-title":"Skin\u2013nervous system interactions","volume":"106","author":"Ansel","year":"1996","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0470","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF01837912","article-title":"Involvement of substance P as a mediator in capsaicin-induced mouse ear oedema","volume":"44","author":"Inoue","year":"1995","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.jconrel.2011.11.016_bb0475","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2133.2008.08683.x","article-title":"Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice","volume":"159","author":"Atarashi","year":"2008","journal-title":"Br. J. Dermatol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911010698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911010698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T04:25:50Z","timestamp":1543379150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365911010698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0168365911010698"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2011.11.016","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}